Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Waldenstrom Macroglobulinemia × Sodium Chloride × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Skin Neoplasms 2 Ovarian Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Hot Flashes 2 Vulvodynia 1 Thromboembolism 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Hemorrhage 1 Pleural Effusion, Malignant 1 Platinum Resistant Ovarian Cancer 1 Parathyroid Neoplasms 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Neutropenia 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1

Interventions

Rituximab 44 fludarabine phosphate 24 Cyclophosphamide 22 Whole-Body Irradiation 21 Peripheral Blood Stem Cell Transplantation 19 Mycophenolic Acid 18 Cyclosporine 14 Tacrolimus 13 Dexamethasone 13 ibrutinib 11 Bortezomib 11 Calcium Dobesilate 10 Busulfan 10 Antilymphocyte Serum 9 Sirolimus 8 Etoposide 8 Methotrexate 7 Lenalidomide 7 Cyclosporins 7 Melphalan 6 Everolimus 6 idelalisib 5 Filgrastim 5 thymoglobulin 4 carfilzomib 4 Indium 4 In Situ Hybridization, Fluorescence 4 Granulocyte Colony-Stimulating Factor 4 Flow Cytometry 4 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡